@article{94b0fcec7e264a68aea65a05e79d851c,
title = "Polymerization of individual species of grass pollen allergens",
abstract = "Six grass pollen allergens have been individually polymerized. We had previously polymerized mixed grass pollen allergens. However, since every patient does not react to every grass, we sought to polymerize individual grasses that could subsequently be mixed into a preparation based on a patient's skin reactivity. As demonstrated by Sepharose 4-B chromatography of individual grass monomers and polymers, all six grasses were polymerized. Polymerized grass preparations as compared with monomer preparations demonstrated a 103- to 105-fold reduction in allergenicity as determined by cutaneous end point titer. That grass polymer contains the great majority of clinically important allergenic determinants was demonstrated by the ability of polymer to inhibit 78% IgE binding against crude grass in a pool of untreated grass-sensitive patients. Its antigenic similarity to crude grasses is further shown by the ability of polymer to inhibit 85% of IgG binding against crude grass in a pool of patients treated with usual crude grass extracts.",
author = "Roy Patterson and Suszko, {Irena M.} and Grammer, {Leslie C.} and Shaughnessy, {Martha A.}",
note = "Funding Information: We have reported the polymerization of a mixture of grass pollen allergens{\textquoteright} and initial limited therapeutic trial results with such a preparation.{\textquoteright} Polymerization of mixed grass pollen allergens would produce a mixed polymer that might not be appropriate for immunotherapy of all patients with grass pollinosis because there are patients with no sensitivity to some components of the grass polymer mixture. For this reason we attempted to polymerize individual grass pollen allergens that were subsequently used in a double-blind histamine placebo-controlled therapeutic trial.3 From the Section of Allergy-Immunology, Department of Medi-cine, Northwestern University Medical School, Chicago. Supported by U.S.P.H.S. Allergy Disease Center Grant AI 11403, the Ernest S. Bazley Grant, and Key Pharmaceutical Co. Received for publication Dec. 6, 1982. Accepted for publication Feb. 4, 1983. Reprint requests: Roy Patterson, M.D., Section of Allergy-Immunology, Department of Medicine, Northwestern University Medical School, Chicago, IL 60611.",
year = "1983",
month = aug,
doi = "10.1016/0091-6749(83)90519-5",
language = "English (US)",
volume = "72",
pages = "129--133",
journal = "The Journal of allergy and clinical immunology",
issn = "0091-6749",
publisher = "Mosby Inc.",
number = "2",
}